Power Law company profile

Crinetics Pharmaceuticals

Biotech & Life Sciences · San Diego, United States · Founded 2008 · IPO 2018 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$3.05B

Market cap · Apr/2026

Revenue

$7.7M

Latest reported FY

Investors

15 investors on Crinetics Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage

5AM Ventures

Versant Ventures

Vivo Capital

Series B+ 12 investors entered at this stage

Adage Capital

Perceptive Advisors

Invus

Driehaus Capital Management

OrbiMed

GordonMD Global Investment

Janus Henderson Investors

EcoR1 Capital

Paradigm BioCapital

RA Capital Management

First Light Asset Management

Rock Springs Capital

Global footprint

Where Crinetics Pharmaceuticals has talent and traffic

Web traffic by country

25K monthly visits
across markets

🇺🇸 United States54.4%

🇮🇳 India23.6%

🇬🇧 United Kingdom10%

🇨🇦 Canada6.4%

🇯🇵 Japan3.6%

Top 5 markets shown

Patent intelligence

$69M patent portfolio · 41 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$69M

2.3% of market cap · 1.5× the top peer Haihe Biopharma ($45M)

41 active patent families

Where Crinetics Pharmaceuticals innovates Pharmaceutical drugDiseaseSomatostatinPharmaceutical SubstancesMolecular biology

Above peer median on Market

Quality vs same-sector peers

Crinetics Pharmaceuticals on the five Patsnap quality dimensions

Crinetics Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Crinetics Pharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Crinetics Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Crinetics Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo